Nov 24, 2008 by Brian Orelli, PhDA Bloody Good Deal for Johnson & Johnson JNJ acquires Omrix. Who might be snatched up next?
Nov 21, 2008 by Brian Orelli, PhDViagra Stays Behind the CounterAll puns about soft sales and wishing something would go up in this market have been removed from this article.
Nov 21, 2008 by Brian Orelli, PhDLigand and Glaxo Like the FDA's AnswerGood news arrives for blood-clot buster Promacta.
Nov 21, 2008 by Brian Orelli, PhDCoughing Is Bad for Amgen's HealthSafety concerns halt drug trial, but all is not lost.
Nov 20, 2008 by Brian Orelli, PhDLike Coupons, Only BetterHow to make money by lowering the cost of health care.
Nov 20, 2008 by Brian Orelli, PhDDouble Trouble for AstraZenecaGeneric woes and a miscue in the pipeline, oh my.
Nov 20, 2008 by Brian Orelli, PhDSanofi Breathing EasierThe drugmaker settles a few patent disputes with generic-drugmaker nemeses.
Nov 19, 2008 by Brian Orelli, PhDDepressing News for DrugmakersAntidepressants aren't that different from each other, says a report.
Nov 18, 2008 by Brian Orelli, PhDIcahn's Next Biotech AdventureWith ImClone done, he's got his eye focused elsewhere.
Nov 18, 2008 by Brian Orelli, PhDGenzyme Grounded for ThanksgivingThe biotech won't get a decision on Myozyme until February.
Nov 18, 2008 by Brian Orelli, PhDNo Buffer for MedtronicEven though sales grew for the quarter, investors weren't happy.
Nov 17, 2008 by Brian Orelli, PhDThe Little Chemotherapy That CouldSlow and steady isn't very exciting.
Nov 17, 2008 by Brian Orelli, PhDBeauty Can Be a BeastPinched pocketbooks likely to hurt cosmetic-pharmaceutical companies more than FDA warning.
Nov 14, 2008 by Brian Orelli, PhDGravy or Turkey From the FDA?These drugmakers should be made aware of their fate over the next few weeks.
Nov 14, 2008 by Brian Orelli, PhDPfizer Takes the Plunge Into Stem-Cell ResearchIt looks like a new unit focusing on this will include work with other companies.
Nov 13, 2008 by Brian Orelli, PhDMerck Could Double Potential CustomersHPV vaccine now recommended for girls and women is also shown to benefit boys and men.
